(Q35263067)

7 August 2017

1 reference

title

Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo (English)

1 reference

7 August 2017

5

G. Karupiah

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1354650

17 September 2022

author name string

I. Ramshaw

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1354650

17 September 2022

J. Ruby

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1354650

17 September 2022

A. Ramsay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1354650

17 September 2022

G. Ada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1354650

17 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1354650

17 September 2022

publication date

1 June 1992

1 reference

7 August 2017

published in

Immunological Reviews

1 reference

7 August 2017

volume

127

1 reference

7 August 2017

page(s)

157-182

1 reference

Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Peyer's patch B cells with memory cell characteristics undergo terminal differentiation within 24 hours in response to interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Interleukin 2-induced proliferation of murine natural killer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

IgG2a restriction of murine antibodies elicited by viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Structure of vaccinia virus early promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Eosinophilia in transgenic mice expressing interleukin 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Interleukin 4 expressed in situ selectively alters thymocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Vaccinia virus expression vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Receptor-directed focusing of lymphokine release by helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Frontiers of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

A primitive immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Functional identity between murine γ Interferon and macrophage activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

[Genetic studies with mammalian poxviruses. I. Demonstration of recombination between two strains of vaccina virus]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01413.X

10.1111/J.1600-065X.1992.TB01413.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference